Association of cognitive impairment with plasma levels of folate, vitamin B12 and homocysteine in the elderly

In Vivo

Volumn 20, Issue 6 B, 2006, Pages 895-900

  Dimopoulos, Nikolaos ^a   Piperi, Christina ^a   Salonicioti, Aristea ^b   Psarra, Vassiliki ^c   Gazi, Flerri ^c   Nounopoulos, Charalambos ^a   Lea, Robert W ^d   Kalofoutis, Anastasios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Health Center   (Greece)

^c Psychiatric Hospital of Attika Dafni   (Greece)

^d UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Dementia; Elderly; Folate; Homocysteine; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMMUNITY; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; STATISTICAL ANALYSIS; VITAMIN BLOOD LEVEL;

EID: 33846067311     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Beers M and Berkow R: World demographics. In: The Merck Manual of Geriatrics. Beers M and Berkow R (eds.). MERCK & CO, pp. 17-20, 2000.
2. Hofman A, Rocca WA and Brayne C: The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Int J Epidemiol 20: 736-748, 1991.
3. Ritchie K and Kildea D: Is senile dementia age-related or ageing-related? evidence from a meta-analysis of dementia prevalence in the oldest-old. Lancet 346: 931-934, 1995.
4. Skoog I, Nilsson L, Palmertz B, Endreasson L and Svanborg, A: A population-based study of dementia in 85-year-olds. New Engl J Med 328: 153-158, 1993.
5. Jorm A, Korten AE and Henderson AS: The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Stand 76: 465-479, 1987.
6. Blennow K: CSF biomarkers for mild cognitive impairment. J Int Med 56: 224-234, 2004.
7. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L and Ueland PM: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurology 55: 1449-1455, 1998.
8. Nilsson K, Gustafson L, Faldt R, Andersson A, Brattstrom L, Lindgren A, Israelsson B and Hultberg B: Hyperhomo-cysteinaemia - a common finding in a psychogeriatric population. Eur J Clin Invest 26: 853-859, 1996.
9. Ouadri P, Fragiacomo C, Pezatti R, Forloni G, Tettamanti M and Lucca U: Homocysteine, folate and vitamin B12 in mild cognitive impairment, Alzheimer's disease and vascular dementia. Amer J Clin Nutrition 80: 114-122, 2004.
10. Wang H, Wahlin A, Basun H, Fastbom J, Winblad B and Fratiglioni L: Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 56: 1188-1194, 2001.
11. Reynolds E: Folio acid, ageing, depression and dementia. Brit Med J 324: 1512-1515, 2000.
12. Bernard M, Nakonezny PA and Kashner TM: The effect of vitamin B12 deficiency on older veterans and its relationship to health. J Amer Geriatrics Soc 46: 1199-1206, 1998.
13. Bell I, Edman JS, Marby DW, Satlin A, Dreier T, Liptzin B and Cole JO: Vitamin B12 and folate status in acute psychogeriatric inpatients: Affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry 27: 125-137, 1990.
14. Miller J, Gren R, Ramos MI, Allen LH, Mungas DM, Jagust WJ and Haan MN: Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. Amer J Clin Nutrition 78: 441-447, 2003.
15. Prins N, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R and Breteler MMB: Homocysteine and cognitive function in the elderly. The Rotterdam Study. Neurology 59: 1375-1380, 2002.
16. Ariogul S, Cankurtaran M, Dagli N, Khalil M and Yavuz, B: Vitamin B12, folate, homocysteine and dementia: are they really related? Arch Gerontol Geriatrics 40: 139-146, 2005.
17. Bjelland I, Tell GS, Vollset SE, Refsum H and Ueland PM: Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch General Psychiatry 60: 618-626, 2003.
18. Lee S, Wing YK and Fong S: A controlled study of folate levels in Chinese inpatients with major depression in Hong Kong. J Affect Dis 49: 73-77, 1998.
19. Ravaglia G, Forti P, Maloli F, Zanardi V, Dalmonte E, Grossi G, Cucinotta D, Macini P and Caldarera M: Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging 4: 218-222, 2000.
20. Clarke R, Refsum H, Birks J, Grimley Evans J, Johnston C, Sherliker P, Ueland PM, Schneede J, Mcpartlin J, Nexo E and Scott JM: Screening for vitamin B-12 and folate deficiency in older persons. Amer J Clin Nutrition 77: 1241-1247, 2003.
21. Bottiglieri T, Hyland K, and Reynolds EH: The clinical potential of adometionine (S-adenosylmethionine) in neurological disorders. Drugs 48: 137-152, 1994.
22. Selhub J, Jacques PF, Wilson PWF, Rush D and Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Amer Med Assoc 270: 2693-2698, 1993.
23. Lipton S, Kim WK, Choi YB, Kumar S, D'emilia, DM, Rayudu PY, Arnelle DR, and Stamler JS: Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Nat Acad Sci USA 94: 5923-5928, 1997.
24. Beal M, Swartz KJ, Finn SF, Mazurek MF, and Kowall NW: Neurochemical characterization of excitoxin lesions in the cerebral cortex. J Neuroscience 11: 147-158, 1991.
25. Sajatovic M and Ramirez L: Geriatric depression scale. In: Rating Scales in Mental Health. Sajatovic M and Ramirez L (eds.). Hudson Cleveland Lexi-Comp INC, pp. 405-406, 2003.
26. Folstein M, Folstein S and Mchugh PR: Mini- Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12: 189-198, 1975.
27. Vertesi A, Lever JA, Molloy DW, Sanderson B, Tuttle J, Pokoradi L and Principi E: Standardized Mini-Mental State Examination; use and interpretation. Canadian Family Physician 47: 2018-2023, 2001.
28. Gorelick P: Risk factors for vascular dementia and Alzheimer's disease. Stroke 35(S1): 2620-2622, 2004.
29. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A and Breteler MM: Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Amer J Epidemiol 150: 283-289, 1999.
30. White AR, Huang X, Jobling MF, Barrow C J, Beyreuther K, Masters CL, Bush AI and Cappal R: Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochemistry 76: 1509-1520, 2001.
31. Kruman I, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L and Mattson MP: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neuroscience 20: 6920-6926, 2000.